177 related articles for article (PubMed ID: 32207069)
1. Mild Hyperuricemia: To Treat, or Not to Treat, That is the Question. Suggestions form the URRAH Study.
Semplicini A
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):119-120. PubMed ID: 32207069
[No Abstract] [Full Text] [Related]
2. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
[No Abstract] [Full Text] [Related]
3. Why better treatment of gout is needed.
So AK
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):63-5. PubMed ID: 27586807
[TBL] [Abstract][Full Text] [Related]
4. Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects.
Cortese F; Giordano P; Scicchitano P; Faienza MF; De Pergola G; Calculli G; Meliota G; Ciccone MM
Vascul Pharmacol; 2019 Sep; 120():106565. PubMed ID: 31152976
[TBL] [Abstract][Full Text] [Related]
5. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
[TBL] [Abstract][Full Text] [Related]
6. The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia - A systematic review and meta-analysis.
Liu CW; Chang WC; Lee CC; Shau WY; Hsu FS; Wang ML; Chen TC; Lo C; Hwang JJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1011-1022. PubMed ID: 31378626
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat for hyperuricemia: experience with patients on chronic hemodialysis treatment.
Horikoshi R; Akimoto T; Inoue M; Morishita Y; Kusano E
Clin Exp Nephrol; 2013 Feb; 17(1):149-50. PubMed ID: 23292179
[No Abstract] [Full Text] [Related]
8. Serum uric acid and the risk of cardiovascular and renal disease.
Borghi C; Rosei EA; Bardin T; Dawson J; Dominiczak A; Kielstein JT; Manolis AJ; Perez-Ruiz F; Mancia G
J Hypertens; 2015 Sep; 33(9):1729-41; discussion 1741. PubMed ID: 26136207
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
10. Approach to the treatment of hyperuricemia.
Poon SH; Hall HA; Zimmermann B
Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
[No Abstract] [Full Text] [Related]
11. Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.
Maloberti A; Giannattasio C; Bombelli M; Desideri G; Cicero AFG; Muiesan ML; Rosei EA; Salvetti M; Ungar A; Rivasi G; Pontremoli R; Viazzi F; Facchetti R; Ferri C; Bernardino B; Galletti F; D'Elia L; Palatini P; Casiglia E; Tikhonoff V; Barbagallo CM; Verdecchia P; Masi S; Mallamaci F; Cirillo M; Rattazzi M; Pauletto P; Cirillo P; Gesualdo L; Mazza A; Volpe M; Tocci G; Iaccarino G; Nazzaro P; Lippa L; Parati G; Dell'Oro R; Quarti-Trevano F; Grassi G; Virdis A; Borghi C;
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):121-128. PubMed ID: 32157643
[TBL] [Abstract][Full Text] [Related]
12. [Gout and cardiovascular risk].
Němec P
Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease
.
Kwak CH; Sohn M; Han N; Cho YS; Kim YS; Oh JM
Int J Clin Pharmacol Ther; 2018 Jul; 56(7):321-327. PubMed ID: 29750634
[TBL] [Abstract][Full Text] [Related]
14. A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout.
Kamatani N; Hosoya T
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S11-2. PubMed ID: 21654264
[No Abstract] [Full Text] [Related]
15. Rasburicase in the treatment of hyperuricemia of newborns.
Ghirardello S; Ardissino G; Mastrangelo A; Mosca F
Pediatr Nephrol; 2010 Sep; 25(9):1775; author reply 1777. PubMed ID: 20376501
[No Abstract] [Full Text] [Related]
16. Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study.
Rozza F; Trimarco V; Izzo R; Grassi D; Ferri C
High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):381-386. PubMed ID: 27644242
[TBL] [Abstract][Full Text] [Related]
17. Gout and arrhythmias: In search for causation beyond association.
Giannopoulos G; Angelidis C; Deftereos S
Trends Cardiovasc Med; 2019 Jan; 29(1):41-47. PubMed ID: 29937218
[TBL] [Abstract][Full Text] [Related]
18. Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study.
Desideri G; Virdis A; Casiglia E; Borghi C;
High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):197-202. PubMed ID: 29427170
[TBL] [Abstract][Full Text] [Related]
19. Critical revision of the medical treatment of gout in Brazil.
Azevedo VF; Lopes MP; Catholino NM; Paiva EDS; Araújo VA; Pinheiro GDRC
Rev Bras Reumatol Engl Ed; 2017; 57(4):346-355. PubMed ID: 28743362
[TBL] [Abstract][Full Text] [Related]
20. Allopurinol and the risk of prostate cancer.
Lai SW; Kuo YH; Liao KF
Postgrad Med J; 2020 Feb; 96(1132):102. PubMed ID: 31292278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
